In cancer, EPO treatment for anemia resulted from successful clinical trials of patients with anemia associated with chemotherapy and with lymphoproliferative malignancies where EPO administration reduced transfusion requirements, increased hemoglobin concentration and decreased fatigue and improved quality of life [197,198,199]. The gene discussed is EPO; the disease is anemia (phenotype).